Newborn screening: new developments, new dilemmas
Journal of Medical Ethics 2005 July; 31(7): 393-398
Scientific and technological advances are lending pressure to expand the scope of newborn screening. Whereas this has great potential for improving child health, it also challenges our current perception of such programmes. Standard newborn screening programmes are clearly justified by the fact that early detection and treatment of affected individuals avoids significant morbidity and mortality. However, proposals to expand the scope and complexity of such testing are not all supported by a similar level of evidence for unequivocal benefit. We argue that screening for genetic susceptibility to complex disorders is inherently different from standard screening and, while of potential value, must be considered separately from conventional testing.
Permanent LinkFind Full Text at Georgetown University Library
Full Text from Publisher
Showing items related by title, author, creator and subject.
Concerns of Newborn Blood Screening Advisory Committee Members Regarding Storage and Use of Residual Newborn Screening Blood Spots Rothwell, Erin W; Anderson, Rebecca A; Burbank, Matthew J; Goldenberg, Aaron J; Lewis, Michelle Huckaby; Stark, Louisa A; Wong, Bob; Botkin, Jeffrey R (2011-11)We assessed attitudes and opinions of members of newborn blood screening (NBS) advisory committees regarding the storage and secondary research use of residual specimens from NBS.
Recent Developments in the Law and Ethics of Embryonic Research: Can Science Resolve the Ethical Problems It Creates? Robertson, Christopher (2005-06)
Robertson, John A; Fost, Norman (1976-05)